Endoscopic submucosal dissection (ESD) allows endoscopic, curative, en-bloc resection of superficial malignant or premalignant lesions. This procedure was conceived over 10 years ago in Japan, but has not experienced great expansion in Western countries for different reasons. This article reviews ESD indications and outcomes, and reflects on the reasons that prevent ESD from becoming common clinical practice in Western hospitals. Finally, recommendations on ESD training in our setting are made.
INTRODUCTION
Endoscopic resection of early gastric cancer (EGC) was first accomplished in Japan in the early 1970s (1) . Deyhle et al. had previously described in 1973 resection of sessile colonic polyps after submucosal saline injection. This maneuver produced lesion elevation and allowed its subsequent excision through snare electrocoagulation. The procedure represents the basis for the techniques known as "inject and cut" resections (2), which were followed by the introduction of endoscopic mucosal resection (EMR) with "injection, elevation and cut" (3) and strip-biopsy (4) .
In 1988, Hirao excised a lesion by initially delimiting it with a circumferential incision and subsequently removing it with a snare, performing what is now known as the hybrid resection technique (5) . In 1992, Inoue performed EMR with a cap placed on the distal end of the endoscope (6) , and in 1997, Akayima accomplished EMR using band ligation (7) .
The hybrid resection technique described by Hirao (5) represented the starting point for the development of endoscopic submucosal dissection (ESD) procedures and finally, in 1999, Gotoda described the first resection according to the ESD technique (8) , whose stages are summarized in figure 1 .
ESD has since greatly expanded in Asian countries such as Japan and Korea, but this process has not occurred in Western countries like Spain.
The purpose of this article is to evaluate the reasons that account for this fact, as well as to make suggestions regarding the conditions that should be implemented in our country in order to introduce the practice of ESD. Before evaluation of these issues, indications and outcomes of ESD are reviewed.
ESD INDICATIONS
ESD indications in any anatomical segment are limited by two factors, namely the resectability of the lesion (a characteristic directly related with its size), and the risk of lymphatic invasion. The risk of lymph node metastases in EGC approaches 3 %, but increases to 20 % when submucosal invasion in present (9) . There are whatsoever small differences depending on the organ involved.
Absolute esophageal ESD indications accepted by the Japanese Esophagus Association include lesions with high grade dysplasia or in situ carcinoma that do not surpass the lamina propria and are restricted to a maximum of two thirds of the circumference (10) . The risk of nodal metastases in these circumstances is inexistent, as has been demonstrated in studies that analyzed a great number of surgical specimens with exhaustive investigation of lymphatic invasion (11, 12) . Extended relative indications are also accepted for high surgical risk patients: Carcinomas with a submucosal invasion depth under 200 μm (sm1), which entail a 10-15 % risk of lymphatic metastases, and lesions involving more than two thirds of the circumference.
It must be kept in mind that virtually all esophageal ESD experience has been developed on squamous carcinoma, because of the low incidence of adenocarcinoma in Asian countries. The incidence of adenocarcinoma on Barrett's esophagus is however greater in Western countries, and this may represent an important field of ESD application in our context. Because this lesion has been scarcely studied in Japanese series, the previously described absolute ESD indications (13) must be carefully followed when considering ESD therapy for esophageal adenocarcinoma.
The standard gastric ESD indication is the resection of well-differentiated intestinal-type adenocarcinoma that is confined to the mucosa and lacks lymphovascular invasion. The neoplasm must be under 20 mm in diameter or under 10 mm when classified as a flat or depressed lesion (Paris 0-IIb or 0-IIc) (14) .
Gotoda et al. proved these criteria to be overly restrictive, as they implied unnecessary surgical therapy for many patients. After analyzing a database with over 5,000 patients who had undergone gastrectomy and R2 lymphatic dissection, they were able to determine with high certainty the risk of node metastases in additional patient groups (15) (Table I) , and consequently defined the expanded ESD indications, which include well-differentiated, non ulcerated mucosal adenocarcinomas of any size, ulcerated adenocarcinomas under 30 mm in diameter and those with submucosal invasion less than 500 μm as long as they do not exceed 30 mm in diameter and lack lymphovascular invasion (16) .
Colorectal ESD is recommended for lesions in which the probability of achieving en bloc resection with a polypectomy snare is low: Polyps with non granular lateral growth (LST-NG), particularly of the pseudo-depressed type; lesions with type VI cryptal pattern and protruded lesions suspected to correspond with carcinoma; fibrotic lesions; sporadic lesions detected in the context of chronic inflammatory diseases such as ulcerative colitis; and non disseminated carcinoma that was not successfully removed after endoscopic mucosal resection (17) . Regarding malignant lesions, mucosal neoplasms or carcinomas with superficial (< 1,000 μm) submucosal invasion without lymphovascular invasion are amenable to ESD as well (18, 19) .
ESD OUTCOMES
The outcomes from the main esophageal, gastric and colorectal ESD series are presented in Tables II, III and IV respectively. Taken together, the data describe an en bloc resection rate for esophagogastric lesions of over 95 %, and near 90 % for colorectal lesions. R0 resection, understood as en bloc resection with tumor-negative resection margins, is achieved in up to 91 % of esophageal lesions, 88 % of gastric lesions and 78 % of colonic and rectal lesions. These results are comparable to the ones described in surgical series. The recurrence rate is very low (around 1 %).
ESD permits complete en bloc resections, which warrant the histological examination of the whole specimen in a reliable way. The completeness of the resection can thus be evaluated, determining if further endoscopic or surgical treatment is required.
ESD therefore represents a safe and curative endoscopic procedure for superficial gastrointestinal lesions with the appropriate histological characteristics.
The most common ESD complication is gastrointestinal bleeding, which may occur in up to 20 % of the cases. Risk factors for bleeding include chronic renal impairment, hepatic cirrhosis and subtotal gastrectomy (20) . The incidence of bleeding is higher in gastric ESD, and the risk increases along with lesion size (> 31 mm). Neoplasms located in the proximal two thirds of the stomach entail also a higher risk (21) . Delayed bleeding taking place 24 hours after the performance of ESD can occur in up to 6 % of the cases, and may be severe (22) . It should be kept in mind that bleeding is in fact inherent to the procedure, for submucosal vessels must be cut. Bleeding should be expected and adequately managed.
The second most common ESD complication is perforation, which occurred in around 5 % of the cases in most studies, but reached 20 % in some series (23) . Over 90 % of such complications can be managed endoscopically (20) .
Pneumotorax is a rare complication that may befall in esophageal, gastroesophageal junction and gastric fundus ESD (20) , and requires procedure cancellation, as it is a life threatening event.
ESD VERSUS ALTERNATIVE THERAPIES
ESD achieves significantly higher en bloc resection rates when performed on gastric (83 vs. 42 %) and colorectal (83.5-98.9 vs. 42.9-83.3 %) lesions compared with EMR. It achieves superior R0 resection rates (83 vs. 24 %) and lower recurrence rates on gastric (4 vs. 18 %) and colorectal (0.2-2.3 vs. 1.4-25.9 %) lesions as well. On the other hand, ESD produces a higher proportion of gastric (2.8-20 vs. < 1 %) and colorectal (3.3-8 vs.2.9 %) perforations, and also a higher percentage of bleeding in both locations (22 vs. 10 % and 1.7-2.4 vs. 1.4-2.9 % respectively) (24) (25) (26) (27) .
Compared with surgery, ESD obtains similar 5-year survival rates (81-98 % depending on the location vs. > 90 % respectively). Recurrence rates are likewise comparable (1-14 % in surgical series, 1-10 % in ESD series). However, morbidity and mortality are lower in ESD series (5-22 % and 0-2 % respectively) than in surgical series (12-80 % and 1-22 % respectively).
Although thus far not thoroughly evaluated in published studies, ESD could entail an improved outcome in quality of life. Patients undergoing oncological surgical treatment do not relate complete recovery until 12 to 24 months after the procedure, and do not regain previous quality of life until 5 years after surgery (28) (29) (30) . Patients deceased during the first two years after the operation are never able to recover their previous quality of life (28) (29) (30) .
DIFFUSION OF ESD IN SPAIN AND WESTERN COUNTRIES
Nevertheless, the advantages listed above, ESD has not experienced such broad diffusion in Western countries as Considering that alternative minimally invasive surgical therapies entail very low morbidity and mortality, the slow pace of ESD introduction may be understood.
ESD difficulty is not only technical, as there are various factors that may increase it. The location of the lesion plays an important role, being distal gastric lesions the most amenable to resection, followed by rectal, proximal gastric, esophageal and colonic lesions. Duodenal lesions are considered the most demanding.
In addition, the location of the lesion within an organ has an influence on difficulty. Posterior wall lesions are harder to resect, as they hinder taking advantage of gravity while performing ESD.
A lesion diameter over 30 mm and the presence of submucosal fibrosis are two factors that may increase ESD difficulty as well (33) .
Another factor that hampers the introduction of ESD in Western countries is a lower incidence of gastric cancer, which makes more difficult acquiring clinical expertise in EGC, the most adequate lesion to begin ESD training. Annual, age adjusted gastric cancer incidence in Japan is 60-70 cases per 100.000 inhabitants, while in Spain male incidence is 25 cases per 100,000 inhabitants, although it varies from central Spain to coastal regions. For instance, in Castilla León an incidence of 44 cases per 100,000 inhabitants has been described (34, 35) .
Moreover, gastric cancer is diagnosed at an EGC stage in less than 20 % of the cases in our country, while in Japan that figure reaches 53 % (35, 36) . Screening programs that facilitate diagnosis in early stages have been introduced in the latter country, but the great difference between both figures still reveals that the strategy to diagnose EGC in our country must be improved. The completion of a training period at a leading institution in the diagnosis and treatment of EGC has been demonstrated effective in Japan as well as in our country (37, 38) .
Because of all these reasons, many Western authors believe that ESD will not become universally introduced in Western countries unless progress in its efficiency is achieved and a means of performing it on outpatients is found (31) .
On the other hand, the fact that as experience and expertise in ESD is obtained, procedure length and complications diminish significantly (39) , is encouraging. A recent European series that included 91 gastric lesions excised through ESD described procedure duration of 153 minutes for the first 49 lesions, which averaged 36.4 mm in diameter. The next 42 lesions, with a diameter of 46.7 mm in average, required 161 minutes in average for their removal (40), a figure that does not significantly differ from the previous one despite the considerable increase in size. The development of new instruments and novel approaches should as well decrease ESD difficulty and morbidity (41) (42) (43) (44) (45) (46) .
Several Spanish groups have published their experience in ESD in an experimental level (44, (47) (48) (49) , while some of them have begun its application on clinical practice. The Vázquez-Sequeiros et al. (47) study described the performance of 6 ESD in a porcine ex-vivo model, followed by another 6 in a living porcine model, and a successful subsequent ESD in a patient with a 3 cm antral lesion.
Parra-Blanco et al. (49) suggested an experimental training model for our country that begins with the observation of procedures performed by experts, followed by training in an ex-vivo animal model, and lastly in a living animal model. Their work described the performance of eleven ESD in each animal model, and they verified that the time required to fulfill ESD in a living model is significantly less than that required to carry out the procedure in an ex-vivo model with a lesion of similar size. This suggests an adequate attainment of skills through the first stage of training. In the discussion of the article the author declares having acquired clinical experience in 5 gastric and one rectal ESD.
A 31 case ESD series performed over a 4 year period has been recently published (50) . The average size of the lesions included was 36 +/-17 mm; 23 of them were located in the rectum and sigmoid colon, one in the esophagus and 7 in the stomach. En bloc excision was achieved in 13 cases (42 %), and R0 resection was observed in 7 lesions (22.6 %). The incidence of perforation and bleeding was 16 % and 26 % respectively, while recurrence occurred in 9 % of the cases. Adequate completion of resection through subsequent endoscopic therapy was achieved in all of them.
Although to the date still evidently scarce, a growing number of hospitals in our country is gathering experience in ESD. In fact, to our knowledge ESD has been applied in clinical practice in at least 12 Spanish hospitals.
ESD TRAINING
The ESD learning curve is long and complicated (51), and is approached differently in Asian and Western countries. In Japan, a sufficient general medicine training to correctly manage patients clinically is required to start instruction, as well as standard endoscopic skills. These skills include the ability to perform routine endoscopy using high definition endoscopes, to detect and characterize mucosal lesions, obtain biopsies, reach the cecum easily, and to master endoscopic hemostatic techniques, polypectomy and EMR (52) .
However, the most valued virtues in a candidate to ESD training regard his or her attitude, as personality and character may affect his/her progress (52) . For that reason, Rev esp enfeRm Dig 2013; 105 (9): 544-552 Japanese experts believe that not every endoscopist may be eligible to perform ESD (52) .
Requirements for an endoscopist in training to start performing the procedure in clinical practice include gathering enough theoretical knowledge, experience and endoscopic skills to grant self-sufficiency. He/she should be able to assess the difficulty of a lesion and refer those that surpass his level of expertise to more experienced endoscopists. He/she should be capable of completing ESD on gastric lesions smaller than 2 cm without ulceration in less than 2 hours, and of achieving over 90 % of curative resections with an incidence of complications under 3 % (52).
In addition to all this, a competent endoscopist should be familiar with all available instruments, as well as with diathermy settings, which vary for each ESD stage depending on lesion location.
Finally, the Japanese training process requires an endoscopist to master gastric ESD before attempting the technique in other locations.
These general recommendations are applied in each institution by means of organized learning programs. In the National Cancer Center in Tokyo, ESD trainees are instructed in several stages. They initially obtain basic notions that permit detection and diagnosis of EGC, as well as ESD indications (53) . In a second stage they observe multiple procedures performed by experts. In a later phase, they prepare and provide instruments to the endoscopist during the procedures, and acquire experience in animal models, where they are expected to complete at least 30 ESD. This phase may extend itself for a year (54) . Eventually they begin performing supervised ESD in clinical practice.
Distal, small EGCs without ulceration or fibrosis are targeted first. Thirty ESD must be completed in that location. Lesions in the proximal two thirds of the stomach are resected subsequently, and 40 such procedures must be accomplished.
An endoscopist is considered competent at colon ESD when he/she has fulfilled 40 procedures in that location.
This training program has demonstrated an excellent capability of rendering self-sufficient trainees who achieve complete resection rates of 100 % and 1.7 % complication rates (53) .
In Western countries the learning curve is approached in a different manner, determined by the circumstances in those nations. In 2008, a board of European experts assisted by Japanese specialists gathered in Rotterdam developed a number of recommendations for the training and performance of ESD (55) ( Table V) .
Concerning the endoscopy unit, the use of high definition sets is endorsed (55) . From our point of view, not only the quality of the image is important, but also the capability of the endoscope to provide adequate angulations that will permit its appropriate location facing the lesion and thus the correct performance of the technique. It is as well advisable to perform ESD with an endoscope equipped with an additional water channel.
Logistics concerning ESD must also be considered. A completely available endoscopy room and endoscopy assisting team, for whatever time is required, are necessary, and the room's schedule must be thus adapted to the requirements of each case. In some cases, the entire working day of an endoscopy room will have to be booked for an ESD procedure.
With regard to clinical practice, and as opposed to Japanese recommendations, it is advised in the West to commence with rectal or distal gastric lesions, followed by colonic lesions, proximal gastric lesions, and finally esophageal lesions (55) . It is also considered imperative performing at least 10-20 ESD per year (55) .
No consensus was however reached by this board regarding whether this technique should be performed exclusively in reference centers, as some Europeans authors endorse (56) .
In our opinion, and although the organization of the health system in our country prevents from restricting the procedure to certain hospitals, it is essential that endoscopists willing to perform ESD complete an adequate training program. Observing at least 15 dissections performed by an expert at his accustomed working environment, which implies visiting reference centers, is highly recommendable when beginning the learning curve. Acquiring enough experience on animal models before progressing to clinical practice is likewise basic. Completing 30 supervised procedures in animal models is difficult to achieve in our environment, but, to our judgment, the requisite of 
Lesion requirements
Step-up approach, starting with lesions presenting in the rectum or in the distal stomach, then colon, proximal stomach, and finally in the esophagus only 5 procedures established by European experts (55) is too scarce. It is as well highly advisable that endoscopists performing ESD in our environment carry on with experimental practice in living animal or ex-vivo models, despite having initiated ESD application in clinical practice. This activity helps to maintain the necessary technical skills regardless of encountering a low number of ESD resectable lesions in their practice. If this recommendation were to be followed, permanent access to an experimental laboratory where these procedures could be carried out should be granted to endoscopists who perform ESD. Once experimental practice has been acquired, following the previously mentioned expert recommendations in clinical practice is advisable. A progressive approach to each group of lesions as experience is gathered must be carried out. The progression should be based on the difficulty of lesions, as determined by their location and characteristics. Disregarding this recommendation may lead to severe complications (23) with detrimental consequences for patients as well as for the technique and the endoscopist.
In summary, ESD is an endoscopic technique that permits curative treatment of pre-malignant and superficial malignant lesions in the gastrointestinal tract, yet technically demanding and with a high risk of complication. These features, combined with a series of limitations, account for its slow diffusion in our health system and imply that it should be initially restricted to a small number of institutions and endoscopists. Several prerequisites should be fulfilled before the application of the technique is generalized in clinical practice. In the first place, the diagnostic rate of EGC should be improved by performing esophagogastroduodenoscopy with higher standards. In the second place, adequate training must be obtained, following the recommendations issued by Japanese and Western experts.
